Related Experiment Video
Updated: Nov 8, 2025

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity
Published on: January 7, 2019
MBNL1 Suppressed Cancer Metastatic of Skin Squamous Cell Carcinoma Via by TIAL1/MYOD1/Caspase-9/3 Signaling Pathways
Jiaorong Chen1, Jiaqi Wang1, Jingyi Qian1
1Department of Anatomy & Embryo-Histology, Basic Medical College, 240515Hubei University of Chinese Medicine, Wuhan, Hubei Province, China.
Objective:
The incidence of skin squamous cell carcinoma (SSCC) has recently been increasing, with diverse clinical manifestations.SSCC could metastasize to lymph nodes or other organs, posing a great threat to life. The present study was designed to investigate the function and underlying mechanism of muscleblind-like protein 1 (MBNL1) in skin squamous cell carcinoma.
Methods:
SCL-1 cell was used for vitro model and transfected with MBNL1 or siMBNL1 plasmids. MTT Assays, LDH activity ELISA, and Transwell chamber migration experiment were used to confirm the effects of MBNL1 on cell growth of SCL-1 cell. Western blot analysis was used to analyze the mechanism of MBNL1 in SCL-1 cell.
Results:
Down-regulation of MBNL1 promoted cell metastasis of SSCC, while up-regulation of MBNL1 reduced cell metastasis of SSCC in vitro. Down-regulation of MBNL1 suppressed the protein expression of T cell intracellular antigen (TIAL1), myogenic determinant 1 (MyoD1) and Caspase-3 in vitro. Consistent with these observations, inhibition of TIAL1 or MYOD1 expression attenuated the effects of MBNL1 in SSCC.
Conclusion:
The present study revealed that MBNL1 suppressed thecancer metastatic capacity of SSCC via by TIAL1/MYOD1/Caspase-3 signaling pathways.
Insights
Muscleblind-like protein 1 (MBNL1) suppresses skin squamous cell carcinoma (SSCC) metastasis by regulating TIAL1/MYOD1/Caspase-3 signaling. MBNL1
Area of Science:
- Oncology
- Molecular Biology
- Dermatology
Background:
- Skin squamous cell carcinoma (SSCC) incidence is rising globally.
- SSCC metastasis poses a significant life-threatening risk.
- Understanding SSCC molecular mechanisms is crucial for effective treatment.
Purpose of the Study:
- To investigate the role of muscleblind-like protein 1 (MBNL1) in SSCC.
- To elucidate the underlying molecular mechanism of MBNL1 in SSCC progression.
Main Methods:
- In vitro study using SCL-1 cells transfected with MBNL1 or siMBNL1.
- Assessed cell growth and metastasis using MTT assays, LDH activity ELISA, and Transwell migration assays.
- Analyzed protein expression changes via Western blot, focusing on TIAL1, MyoD1, and Caspase-3.
Main Results:
- MBNL1 down-regulation enhanced SSCC cell metastasis in vitro.
- MBNL1 up-regulation reduced SSCC cell metastasis in vitro.
- MBNL1 influenced the expression of TIAL1, MyoD1, and Caspase-3, with TIAL1/MyoD1 inhibition affecting MBNL1's role.
Conclusions:
- MBNL1 acts as a suppressor of SSCC metastatic capacity.
- The TIAL1/MYOD1/Caspase-3 signaling pathway mediates MBNL1's function in SSCC.
- MBNL1 represents a potential therapeutic target for inhibiting SSCC metastasis.
More Related Videos
Related Concept Videos
Abnormal Proliferation
The Intrinsic Apoptotic Pathway

